Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jon Nardozzi"'
Autor:
Jon Nardozzi, Kate L. Stokes, Ditte Elisabeth Jæhger, Thomas Lars Andresen, Douglas S. Jones, Hólmfrídur Rósa Halldórsdóttir, Katharine Sackton, Gulzar Ahmad, Alvin Pratama
Publikováno v:
Cancer Immunology Research. 9:PR012-PR012
Despite the promise of adoptive cell therapy (ACT) in the treatment of some cancer types, success against solid tumors remains elusive due to multiple immune escape pathways. T cell therapies that affect tumor microenvironment or provide adjuvant act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::532d994b05feaaf5a1c40491c1ec3c36
https://doi.org/10.1158/2326-6074.tumimm20-pr012
https://doi.org/10.1158/2326-6074.tumimm20-pr012
Autor:
Elena Geretti, Jesse Lyons, Andy Rakestraw, Doug Jones, Becker Hewes, Shawn P. Carey, Aaron Handler, Fabio Fachin, Christine McInnis, Ferdinando Pucci, Austin Boesch, Philip D. Bardwell, Jon Nardozzi, Pengpeng Cao, Jonathan Fitzgerald, Amy Shaw, Thomas Lars Andresen, Carlos Tassa, David Chirgwin, Ulrik B. Nielsen, Khristianna Jones, De-Kuan Chang
Publikováno v:
Cancer Research. 78:3577-3577
Cell therapies have demonstrated clinical benefit for some patients; however, in more resistant tumors, efficacy, persistence, and cell expansion may be improved with co-administration of an inflammatory cytokine such as interleukin 15 (IL-15). Clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a8d345aa755448b6a1da75618c6355b
https://doi.org/10.1158/1538-7445.am2018-3577
https://doi.org/10.1158/1538-7445.am2018-3577